Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via other means.
Data must not be lost when patients do not come to site for several weeks, data quality must be guaranteed throughout the project, and data must be protected even when patients use their own mobile.
How can the common pitfalls that come with DCTs be avoided?
CONTENT
#1 Avoiding data loss when patients visit frequency is reduced
#2 Tackling technology adoption risks
#3 Securing data quality when collecting data from multiple sources
#4 Ensuring data protection
Read the full white paper 👇
